ES2095985T3 - Analogos de fosfato de inositol como sustancias antagonistas del calcio. - Google Patents

Analogos de fosfato de inositol como sustancias antagonistas del calcio.

Info

Publication number
ES2095985T3
ES2095985T3 ES92110563T ES92110563T ES2095985T3 ES 2095985 T3 ES2095985 T3 ES 2095985T3 ES 92110563 T ES92110563 T ES 92110563T ES 92110563 T ES92110563 T ES 92110563T ES 2095985 T3 ES2095985 T3 ES 2095985T3
Authority
ES
Spain
Prior art keywords
inositol phosphate
phosphate analogs
calcium substances
antagonist calcium
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92110563T
Other languages
English (en)
Inventor
Werner Dr Schiebler
Elke Deckert
Eric Dr Dreef
D Marel Geijs Dr V
Boom Jacques Prof Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2095985T3 publication Critical patent/ES2095985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4081—Esters with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

SE PRESENTA UN COMPUESTO DE LA FORMULA (I) EN LA QUE R1 ES POR EJEMPLO FOSFATO, R2 ES POR EJEMPLO FOSFATO O OH, Y R4 ES POR EJEMPLO LA SIGUIENTE FORMULA LOS ANALOGOS SON ANTAGONISTAS ADECUADOS DEL CALCIO Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
ES92110563T 1991-06-26 1992-06-23 Analogos de fosfato de inositol como sustancias antagonistas del calcio. Expired - Lifetime ES2095985T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91110546 1991-06-26

Publications (1)

Publication Number Publication Date
ES2095985T3 true ES2095985T3 (es) 1997-03-01

Family

ID=8206868

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92110563T Expired - Lifetime ES2095985T3 (es) 1991-06-26 1992-06-23 Analogos de fosfato de inositol como sustancias antagonistas del calcio.

Country Status (11)

Country Link
US (1) US5395828A (es)
EP (1) EP0520372B1 (es)
JP (1) JP3161813B2 (es)
KR (1) KR930000527A (es)
AT (1) ATE145911T1 (es)
CA (1) CA2072303A1 (es)
DE (1) DE69215588T2 (es)
DK (1) DK0520372T3 (es)
ES (1) ES2095985T3 (es)
GR (1) GR3022546T3 (es)
HU (2) HUT64081A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000586A2 (en) * 1994-06-30 1996-01-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for treating cell proliferative disorders by modulating signal transduction
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
EP1331932B1 (en) * 2000-11-09 2007-04-04 Contrimmune Biotechnology Inc. Use of xestospongin c for treating or preventing hiv infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
US4474806A (en) 1982-05-10 1984-10-02 Merck & Co., Inc. Sulfonyl or carbonyl inositol derivatives useful as anti-inflammatory/analgesic agents
WO1987005598A1 (fr) * 1986-03-11 1987-09-24 Mitsui Toatsu Chemicals, Incorporated Derives de myoinositol et procede de preparation
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane

Also Published As

Publication number Publication date
CA2072303A1 (en) 1992-12-27
HUT64081A (en) 1993-11-29
DE69215588D1 (de) 1997-01-16
GR3022546T3 (en) 1997-05-31
JP3161813B2 (ja) 2001-04-25
HU211491A9 (en) 1995-11-28
KR930000527A (ko) 1993-01-15
JPH05213975A (ja) 1993-08-24
DK0520372T3 (da) 1997-05-12
EP0520372B1 (en) 1996-12-04
US5395828A (en) 1995-03-07
HU9202103D0 (en) 1992-10-28
ATE145911T1 (de) 1996-12-15
EP0520372A1 (en) 1992-12-30
DE69215588T2 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
IL94915A0 (en) Substituted quinazolinones and pharmaceutical compositions containing them
DK0791571T3 (da) Benzoylderivater
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
YU46738B (sh) Postupak za dobijanje benzodiazepina
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
NO931917D0 (no) Farmasoeytiske forbindelser
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.
IL103305A0 (en) Cardioprotective tocopherol analogs
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE69033069D1 (de) Prostaglandinanaloge
ES2060239T3 (es) Analogos de bis(alquil-sustituido-4-hidroxifeniltio)alcano como inhibidores de la formacion de cataratas.
ZA883444B (es)
FI882358A0 (fi) Cykliska antikoagulationspeptider.
FR2698628B1 (fr) Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
NO891894L (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales
DE68902490D1 (de) Pharmazeutische zusammensetzung.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ES2044422T3 (es) Composiciones farmaceuticas conteniendo acido 1-isopropildihidrolisergico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 520372

Country of ref document: ES